J. Joseph Kim

2021

In 2021, J. Joseph Kim earned a total compensation of $6.2M as President and Chief Executive Officer at Inovio Pharmaceuticals, a 32% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$451,356
Option Awards$2,625,258
Salary$844,056
Stock Awards$2,289,930
Other$13,000
Total$6,223,600

Kim received $2.6M in option awards, accounting for 42% of the total pay in 2021.

Kim also received $451.4K in non-equity incentive plan, $844.1K in salary, $2.3M in stock awards and $13K in other compensation.

Rankings

In 2021, J. Joseph Kim's compensation ranked 2,034th out of 12,405 executives tracked by ExecPay. In other words, Kim earned more than 83.6% of executives.

ClassificationRankingPercentile
All
2,034
out of 12,405
84th
Division
Manufacturing
777
out of 5,494
86th
Major group
Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks
80
out of 798
90th
Industry group
Surgical, Medical, And Dental Instruments And Supplies
51
out of 519
90th
Industry
Surgical and Medical Instruments and Apparatus
34
out of 324
90th

Pay ratio

J. Joseph Kim's Pay$6,223,600
Median Employee's Pay$180,313
Pay Ratio

35

to 1

In 2021, the annual total compensation of J. Joseph Kim was $6,223,600.

The annual total compensation of the median employee at Inovio Pharmaceuticals was $180,313.

The ratio of J. Joseph Kim's pay to the pay of median employee was therefore 35 to one.

Source: SEC filing on March 25, 2022.

Kim's colleagues

We found three more compensation records of executives who worked with J. Joseph Kim at Inovio Pharmaceuticals in 2021.

2021

Jacqueline Shea

Inovio Pharmaceuticals

Chief Operating Officer

2021

Peter Kies

Inovio Pharmaceuticals

Chief Financial Officer

2021

Laurent Humeau

Inovio Pharmaceuticals

Chief Scientific Officer

News

You may also like